Yu D - Search Results

1

Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth.

Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, Li M, Wang X, Zhang C, Wang H, Ellis K, Cheerathodi M, McCarty JH, Palmieri D, Saunus J, Lakhani S, Huang S, Sahin AA, Aldape KD, Steeg PS, Yu D. Zhang L, et al. Among authors: yu d. Nature. 2015 Nov 5;527(7576):100-104. doi: 10.1038/nature15376. Epub 2015 Oct 19. Nature. 2015. PMID: 26479035 Free PMC article.

2

Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.

Tan M, Yao J, Yu D. Tan M, et al. Among authors: yu d. Cancer Res. 1997 Mar 15;57(6):1199-205. Cancer Res. 1997. PMID: 9067293

3

Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.

Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D. Yao J, et al. Among authors: yu d. Clin Cancer Res. 1998 Apr;4(4):1065-70. Clin Cancer Res. 1998. PMID: 9563903

4

Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase.

Yu D, Jing T, Liu B, Yao J, Tan M, McDonnell TJ, Hung MC. Yu D, et al. Mol Cell. 1998 Nov;2(5):581-91. doi: 10.1016/s1097-2765(00)80157-4. Mol Cell. 1998. PMID: 9844631 Free article.

5

Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.

Zhang L, Yu D, Hu M, Xiong S, Lang A, Ellis LM, Pollock RE. Zhang L, et al. Among authors: yu d. Cancer Res. 2000 Jul 1;60(13):3655-61. Cancer Res. 2000. PMID: 10910082

6

Up-regulation of vascular endothelial growth factor in breast cancer cells by the heregulin-beta1-activated p38 signaling pathway enhances endothelial cell migration.

Xiong S, Grijalva R, Zhang L, Nguyen NT, Pisters PW, Pollock RE, Yu D. Xiong S, et al. Among authors: yu d. Cancer Res. 2001 Feb 15;61(4):1727-32. Cancer Res. 2001. PMID: 11245489

7

Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells.

Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D. Yao J, et al. Among authors: yu d. Oncogene. 2001 Dec 6;20(56):8066-74. doi: 10.1038/sj.onc.1204944. Oncogene. 2001. PMID: 11781819

8

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

Nagata Y, Lan KH, Zhou X, Tan M, Esteva FJ, Sahin AA, Klos KS, Li P, Monia BP, Nguyen NT, Hortobagyi GN, Hung MC, Yu D. Nagata Y, et al. Among authors: yu d. Cancer Cell. 2004 Aug;6(2):117-27. doi: 10.1016/j.ccr.2004.06.022. Cancer Cell. 2004. PMID: 15324695 Free article.

9

ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.

Tan M, Li P, Klos KS, Lu J, Lan KH, Nagata Y, Fang D, Jing T, Yu D. Tan M, et al. Among authors: yu d. Cancer Res. 2005 Mar 1;65(5):1858-67. doi: 10.1158/0008-5472.CAN-04-2353. Cancer Res. 2005. PMID: 15753384

10

Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.

Tan M, Li P, Sun M, Yin G, Yu D. Tan M, et al. Among authors: yu d. Oncogene. 2006 Jun 1;25(23):3286-95. doi: 10.1038/sj.onc.1209361. Epub 2006 Jan 23. Oncogene. 2006. PMID: 16407820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,948 results

Search Page

Filters